SBI Inc. is currently working with a Research and Development affiliate, Stellar Biomolecular Research in Germany to capitalise on future market demands.
The global biological treatment industry is set to grow at an unprecedented rate of 39.5% from 2015 to 2020 and poised to reach $330 million by year 2020.
Source: ‘Markets and Markets’ – 2014
A team of international manufacturing consultants, biochemist and biomolecular research therapists collaborate across several disciplines to help innovate new and exciting breakthroughs for the company’s product range.
These innovations are utilised by the SBI Group for the further expansion of the group’s in-house brands or used in collaboration with OEM brand owners.